Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Clinical and Vaccine Immunology : CVI|March 14, 2014
Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme diseaseGiacomo Signorino, Paul M Arnaboldi, Mary M Petzke, et al.Clinical and Vaccine Immunology : CVI|February 1, 2013
Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme diseasePaul M Arnaboldi, Rudra Seedarnee, Mariya Sambir, et al.Biochemistry|January 20, 1981
Photochemical and functional properties of bacteriorhodopsins formed from 5,6-dihydro- and 5,6-dihydrodesmethylretinalsB Mao, R Govindjee, T G Ebrey, et al.Pathogens (Basel, Switzerland)|February 23, 2024
Immune Mediators Important for a Protective Secondary Response to Babesia microtiJoseph Conti, Thomas Gagliardi, Paul M Arnaboldi, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1995
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a clinicopathological and genetic study of a Swiss familyH H Jung, C Bassetti, E Tournier-Lasserve, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2021
Detection of IFN-γ Secretion in Blood Samples Collected Before and After Treatment of Varying Stages of Lyme DiseasePaul M Arnaboldi, Christina D'Arco, Yosefa Hefter, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2016
Detection of IFN-γ Secretion by T Cells Collected Before and After Successful Treatment of Early Lyme DiseaseSteven M Callister, Dean A Jobe, Aleksandra Stuparic-Stancic, et al.Pathogens (Basel, Switzerland)|October 25, 2024
Tumor Necrosis Factor Receptors and C-C Chemokine Receptor-2 Positive Cells Play an Important Role in the Intraerythrocytic Death and Clearance of Babesia microtiDana G Mordue, Adiya S Katseff, Andrew J Galeota, et al.International Immunopharmacology|June 5, 2003
Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicityVictor C Huber, Bernard P Arulanandam, Paul M Arnaboldi, et al.Vaccine|October 18, 2016
Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plaguePaul M Arnaboldi, Mariya Sambir, Christina D'Arco, et al.Pageof 3